The ruthenium(Ill) complex Hind trans- [RuCl,(ind) 
Introduction
Today, cisplatin is a well established chemotherapeutic drug, especially against testicular carcinomas, but expansion to a different or broader antitumor spectrum has not been obtained with cisplatin or direct analogues, like carboplatin. Some new developments like orally administrable platinum complexes or combination therapy are promising, but attention is more and more directed to non-platinum antitumor metal compounds. Among others, ruthenium complexes of the oxidation state +11 and +111 are under current investigation as alternative drugs to platinum-based tumor inhibitors [1, 2, 3, 4] . Because of their different chemical characteristics and kinetics, the mode of action and spectrum of activity of these ruthenium compounds should differ significantly from the known platinum complexes. They possess a different redox behavior and undergo different hydrolysis reactions. As a result, a different interaction with biological targets can be expected and detected. Especially ruthenium(Ill) complexes of the general formula HL[RuCI4L2], with two transstanding heterocyclic ligands L bound to ruthenium via nitrogen, show remarkable activity in different tumor models in vitro and in vivo. They exhibit excellent activity in an autochthonous colorectal tumor model, which is comparable to human colon tumors in its histological appearance and behavior against chemotherapeutics, with a tumor reduction of about 70% to 90% [5, 6] . Cisplatin is completely inactive in this model. Furthermore, these Ru(lll)-complexes show antiproliferative activity in two human colon cancer cell lines (SW707 and SW948) [7] . The most promising complex contains two trans-standing indazole (L = ind) ligands. It exhibits antineoplastic effects on proliferation of clonogenic cells from freshly explanted human tumors in a capillary soft agar cloning system [8] . Compared to the also very active imidazole (L = im) complex it is less toxic. The slightly different activity and significantly different toxicological profile of the imidazole and indazole complexes might be due to their different hydrolysis reactions and kinetics and binding preferences for biological targets. Aquation is an important step in the activation of cisplatin [9] and aqua complexes, in general, are orders of magnitude more labile than the corresponding chloro complexes [10, 11, 12] . It is also known that only aged aqueous solutions of Him trans-[RuCl,(im)2] react with DNA [13] . Therefore [14, 15, 16] . In each case hydrolysis to a monoaqua complex has been proposed in unbuffered aqueous solution, followed by the formation of both of the possible diaqua complex isomers with trans-standing imidazoles. The situation in phosphate-buffered solution was found to be more complicated. Here we report on the solvolysis in ethanol, acetonitrile and dimethylsulfoxide and the hydrolysis of the indazole complex trans-[RuCI4(ind)2] (see figure a) . We investigated the indazolium as well as the sodium salt, the latter showing improved solubility in water. [19, 20] . The most upfield shifted signal at a chemical shift of-13.0 ppm represents the two protons at position 3 of the two equivalent indazole ligands. The signal at -7.1 ppm can be assigned to each proton at N-2 because it disappears, due to rapid exchange, on addition of DO. The less broad and upfield shifted peaks at 2.45 (2 h at C-4 or C-7), 2.63 (2 H at C-7 or C-4), 3.18 (2 H at C-5 or C-6) and 4.32 ppm (2 H at C-6 or C-5), that can be assigned in pairs because of corresponding cross-peaks in the H,H-COSY experiment, represent the protons of the indazole ligands with a greater distance to the paramagnetic Ru(lll)-center [18] . The possibility that the spectra in a fresh solution of Na trans-[RuCl,(ind)] do not represent the structure determined for the solid complex salt [18] The changes observed in the UV/vis-spectra also confirm [21] . As in the case of acetonitrile, no change in the 1H NMR of Na trans-[RuCl,(ind)2] can be observed in absolute dmso-d6 solution within a week. The signals at-11.0 (2 H at C-3),-6.1 (2 H at N-2), 2.49 (2 H at C-4 or C-7), 3.22 (4 H at C-7 or C-4 and C-5 or C-6) and 4.40 ppm 2 H at C-6 or C-5) remain unchanged in intensity and chemical shift. The UV/vis-spectra in absolute dmso don't give any evidence for a transformation of the ruthenium complex either. In contrast, the spectra of Na trans-[RuCI4(ind)2] change significantly in dmso water mixtures.
The UV/vis spectrum after 12 hours at 37C is totally different from the spectrum in acetonitrile water and also different from the spectrum in water (see below). After one hour a band occurs at 610 nm (in water at 580 nm), whereas the band at 377 The transformation into one main solvolysis product is also obvious in the UV/vis spectra taken at a temperature of 37C during the first six hours (see figure 5a) . The In an ethanol/water mixture (1/1) the changes in the UV/vis-spectra are different. In contrast to the spectra in pure ethanol, a band rises at 578 nm (see figure 5b) . The [17] . The crystals could be obtained by evaporating a solution of H(1-Me-ind) trans-[RuCl3(HO)(1-Me-ind)] in acetone water (1/1). In contrast to the NMR experiments, changes of a solution of Na trans-[RuCI4(ind)] in water can be seen in the UV/vis-spectra. Figure 5a shows the changes in the UV/vis spectra during the first eight hours at 37C. Together with the formation of a band at 578 nm a diffused background absorption caused by precipitation can be observed, resulting in an increased baseline. Nevertheless, one has to be aware of the more than 100 times smaller concentration of Na trans-[RuCI4(ind)2] in the solution of the UV/vis compared to the NMR experiment. Therefore, different hydrolysis pathways can not be excluded. Hydrolysis, of course, proceeds slower at room temperature or at 4C, where no changes in UV/vis spectra can be observed even after days. This is important to notice with regard to a clinical application and storage of solutions of Na trans-[RuCl4(ind)]. 
